T-Therapeutics
T-Therapeutics is a biotechnology company developing T-cell receptor therapeutics for oncology and inflammatory diseases.
Sponsor licence details
Sourced from the UK Home Office register of licensed sponsors.
About T-Therapeutics
T-Therapeutics is a biotechnology research company that develops T-cell receptor (TCR) based therapeutics. Spun out from the University of Cambridge, the company utilises its proprietary OpTiMus platform, which features a fully humanised TCR mouse, to generate a diverse range of antigen-specific human TCRs.
The business integrates mouse genome engineering, biopharmaceutical drug development, single-cell genomics, machine learning, and structural biology. It operates in the biotechnology sector to create biologics and TCR therapies.
Open roles
1 live position matched to this sponsor licence.